Clinical trial
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2…
NCT00108004 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00108004 |
|---|---|
| Title | Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus |
| Official title | A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | pramlintide acetate |
| Enrollment | 400 |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Apr 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: